-

Meet with the OrganaBio executives in-person at The Cell & Gene Meeting on the Mesa

MIAMI--(BUSINESS WIRE)--The 2022 Cell & Gene Meeting on the Mesa annual conference will be held in Carlsbad, California, on October 11-13, 2022, bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. Meet with the OrganaBio team to learn about our reliable supply of high-quality, ethically sourced tissue and cellular raw materials with clear paths to clinical translation, and the advanced processing and characterization capabilities we offer to speed up novel therapeutic development.

OrganaBio’s CEO, Justin Irizarry, and VP of Corporate Development, Dr. Priya Baraniak, will join the over 1,700 attendees, and will be available for one-on-one meetings to discuss available solutions to cell therapy developers.

www.organabio.com

Contacts

Dr. Priya Baraniak
Vice President of Corporate Development
priya@organabio.com

OrganaBio, LLC

Details
Headquarters: South Miami, FL
CEO: Justin Irizarry
Employees: 50
Organization: PRI

Release Versions

Contacts

Dr. Priya Baraniak
Vice President of Corporate Development
priya@organabio.com

Social Media Profiles
More News From OrganaBio, LLC

OrganaBio and RxMP Therapeutics Announce Manufacturing Partnership to Advance RMP-402 Hemostatic Drug Product

MIAMI & SANTA FE, Calif.--(BUSINESS WIRE)--OrganaBio and RxMP Therapeutics announced a manufacturing partnership for the cGMP production of RMP-402, a first-in-class hemostatic therapeutic....

OrganaBio Expands to the San Francisco Bay Area with New PBMC Processing Laboratory in Hayward, California

SAN FRANCISCO--(BUSINESS WIRE)--OrganaBio opens up a new PBMC processing lab in the Greater San Francisco area to support rapid isolation of PBMCs from clinical trial samples...

OrganaBio Approved as A Science Exchange and Scientist.com Partner

MIAMI--(BUSINESS WIRE)--OrganaBio products and services can now be accessed via the Science Exchange and Scientist.com platforms. Both online marketplaces allow buyers to find and request services directly through the platform and help streamline communication and buying processes through standardized proposal and contracting mechanisms. Drug developers can now leverage www.scienceexchange.com and www.scientist.com and search for OrganaBio’s services and products specifically (e.g. donor screen...
Back to Newsroom